BridgeMD
New treatment option for SCHIZOPHRENIA 1 (Disorder)
Official title Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
ClinicalTrials.gov ID: NCT07469384
What this study is testing
- What it's testing
- This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the scalp to influence underlying brain function.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Male or female subject, age 18-55
- Competent and willing to sign informed consent
- No more than moderately ill
- SCID DSM-5 diagnosis of Sz/SzAff
- WAIS IQ \>70
You likely can't join if
- Significant neurological illness or history of significant head trauma
- Unstable physical illness or significant auditory/visual deficits that might interfer
- Contraindication to MRI (e.g. metal implants, claustrophobia, pregnancy)
- Contraindications to tDCS including metal implant, pacemaker, history of seizure, traumatic brain injury or stroke
- Significant risk for suicide
- Has a history of an illness, disease, condition injury, or disability which, in the opinion of the principal investigator, may interfere with the...
See the full eligibility criteria
- Male or female subject, age 18-55
- Competent and willing to sign informed consent
- No more than moderately ill
- SCID DSM-5 diagnosis of Sz/SzAff
- WAIS IQ \>70
- Does not meet current criteria for DSM-5 defined substance abuse or dependence or have a history of diagnosis within past 6 months
- On medication within clinically approved range
- Does not meet criteria for another DSM-5 disorder other than those judged to be minor (e.g. simple phobia)
- Significant neurological illness or history of significant head trauma
- Unstable physical illness or significant auditory/visual deficits that might interfer
- Contraindication to MRI (e.g. metal implants, claustrophobia, pregnancy)
- Contraindications to tDCS including metal implant, pacemaker, history of seizure, traumatic brain injury or stroke
- Significant risk for suicide
- Has a history of an illness, disease, condition injury, or disability which, in the opinion of the principal investigator, may interfere with the completion of all study requirements per protocol, impact the quality of...
- Moderate or greater DSM-5 current substance use disorder, defined based on the presence of 4 or more of 11 substance use criteria within the past 12 months. In addition, individuals for whom substance use leads to not...
The study team makes the final eligibility decision.
Where it's taking place
- Orangeburg, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orangeburg, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.